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ABSTRACT 
Objective: The aim of this study is to assess the incidence, clinical pattern, factors associated and outcome of 
Aggressive Posterior Retinopathy of Prematurity (APROP) in a tertiary care hospital in South India.  
Methods: A prospective follow up study was done by screening 1738 preterm babies with gestational age <34 weeks 
and or birth weight <1500 grams for a period of four years from March 2012 to February 2016. ROP of any severity 
was present in 412 cases of which 18 cases had APROP. Regression pattern was assessed by fundus examination at 
periodic intervals. Structural and functional outcome were determined at the end of one year in babies with APROP. 
Diode laser photocoagulation was done in all cases and additional intravitreal  bevacizumab injection was given in 6 
eyes of 4 babies.    
Results: The incidence of APROP among the study population was 1.03% and among ROP cases were 4.37%. 
Important maternal risk factors were primigravida, multiple pregnancy and delivery by vaginal route. Significant 
postnatal risk factors included hyaline membrane disease and surfactant use. The mean post conceptional age of 
treatment was 32.2 weeks. Favourable structural outcome accounted for 90% of cases. Association of structural 
outcome with ROP parameters showed significance for pre retinal hemorrhage and fibro vascular proliferation. The 
predominant refractive error was myopia which was present in 17 eyes of which high myopia was present in 10 eyes. 
Strabismus was present in 8 eyes of 4 patients. 
Conclusions: Aggressive posterior form of ROP has reasonably good structural and functional outcome if detected 
and treated early even with laser. Pre retinal hemorrhage and fibro vascular proliferation are associated with poor 
structural outcome. 
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Introduction 
Retinopathy of prematurity (ROP) is a 
vasoproliferative disorder of developing retinal 
vessels seen in preterm newborns. Since the 
advent of recent developments in resuscitation and 
monitoring in neonatal intensive care units, and 
consequent improved survival rate of premature 
babies, retinopathy of prematurity is emerging as 
a significant cause of visual disability in children 
of developing countries like India.
[1]
 The 
aggressive posterior form of retinopathy of 
prematurity (APROP) has the worse anatomical 
and functional outcome, as compared to the 
classic form of the disease.
[2]
  
Laser photocoagulation is the gold standard 
treatment for proliferative ROP and has proven 
useful in reducing progression of classic ROP.
[3] 
However, in treating aggressive posterior retin-
opathy of prematurity, a more severe and unusual 
form of ROP, laser photocoagulation often fails to 
stop its progression to retinal detachment even 
with timely and complete treatment.
[4] 
Intravitreal 
injection of anti-vascular endothelial growth 
factor (VEGF) has now become popular in the 
management of severe ROP. 
 
Materials and Methods 
A hospital based prospective screening study was 
done for 4 years during the period May 2012 to 
April 2016 enrolling 1738 premature babies <1.5 
kg and or <34 weeks of gestational age. Among 
these 412 babies developed ROP of varying 
severity, of which 18 babies developed APROP. 
The initial eye examination was conducted by 31 
weeks postmenstrual age or 4 weeks chronologic 
age, whichever is later.
[5]
 To enable early 
identification and treatment of AP-ROP, infants < 
28 wk or < 1200 g birth weight were screened 
relatively earlier at 2-3 wk of age.
[6]
 
Ocular examination of these preterm infants were 
done after dilating with 1% tropicamide and 2.5% 
phenyl ephrine eye drops applied ten minutes 
apart one hour before the examination. Indirect 
ophthalmoscopic examination was done using 28 
D lens with the help of Alphonso speculum and 
scleral depressor. APROP was categorized 
separately from classical ROP, with the following 
distinguishing features: very severe “plus disease,” 
posterior location (most commonly in zone I but 
also possible in posterior zone II), ill-defined or 
no ridge, arteriovenous shunting throughout the 
posterior pole and dilated tortuous vessels in a 
syncytial pattern.
[7] 
The diagnosis of AP-ROP was 
according to the international classification of 
retinopathy of prematurity (ICROP, 2005)
[8]
. AP-
ROP was defined as a flat network of 
neovascularization in posterior pole associated 
with increased dilatation and tortuosity in all 4 
quadrants. Zone I was defined as a circle with the 
radius that extends from the center of the optic 
disc to twice the distance from the center of the 
optic disc and the central macula. Posterior zone II 
was defined as a circle whose radius is three times 
the distance between the center of the optic disc 
and the center of the macula. Persistent ROP was 
defined as the lack of adequate regression of ROP. 
Recurrence was defined as arrest of anterior 
progression of retinal vasculature with new 
demarcation line, ridge, or extraretinal fibrova-




Treatment was done within 48 hours of diagnosis 
with Diode laser photocoagulation (810 nm 
Oculight SLx, Iridex Co, LA, USA) in all 
cases with parameters of 200 mW power  for 200 
ms duration to achieve a grey white burn.  The 
total number of burns per eye varied from 2000 to 
3000, in 1 or 2 sessions. If ROP failed to regress 
retreatment was done one week after the initial 
treatment. These eyes were followed up until 
regression of disease. Intravitreal antiVEGF 
injection, (Bevacizumab) 0.625 mg in 0.025 mL, 
was given 1.5 to 2 mm away from the limbus, 
with a 30 G needle in persistent disease  or 
recurrence. The patients were re examined the 
next day and then every week to monitor the 
regression of the disease. The parameters analyzed 
include, gestational age, birth weight, postconc-
eptional age of treatment, APROP characteristics, 
regression, number of laser burns and sittings 
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needed. Structural outcome, refraction by 
retinoscopy, and ocular motility were assessed at 
the end of one year. The associated maternal and 
postnatal risk factors were assessed and structural 
outcome in association with the ROP 
characteristics and postnatal factors were analyzed. 
Structural outcome was classified as favourable 
and unfavourable. Favourable outcome includes 
(1) completion of full retinal vascularisation (2) 
progression of vascularisation into zone 3 without 
previous zone 2 disease (3) Post Conceptional age 
of 45 weeks without developing atleast type 2 
ROP.  
Unfavourable outcome  according to ETROP 
includes
[10]
 1)posterior retinal fold involving 
macula 2) retinal detachment involving macula 3) 
fibrosing tissue obscuring view of posterior pole. 
The various retinal structural sequelae studied 
included narrowing of arcades, macular drag, disc 
drag, vitreal membranes, and presence of 
localized peripheral tractional detachment.  
Functional outcome was analysed by doing 
Cycloplegic refraction, done at one year of age 
using atropine.  Refractive errors  in terms of 
spherical equivalence was calculated from the 
retinoscopy readings.
[11] 
Emmetropia is termed as  
0 to 4 dioptres and hypermetropia  as > 4  
diopters.
[12]
 Myopia is classified into low myopia 
0 to -3dioptres,moderate myopia -3 to -6 dioptres 
and high  myopia > - 6 diopters. 
 
Statistical Analysis 
Quantitative variables are expressed as mean ± 
standard deviation and qualitative variables are 
expressed as percentage. Chi-square test was used 
to find association of structural outcome with post 
natal factors and ROP parameters. For all 
statistical interpretations, a p<0.05 was considered 
the threshold for statistical significance.  Ethical 
clearance was obtained from the institutional 
ethics committee and informed consent of parents 
was obtained. The study conforms to the 
guidelines of Declaration of Helsinki. Statistical 
analysis was performed using SPSS version 
17.0(Statistical Package for Social Sciences IBM 
Corp., New York, NY, USA). 
 
Results 
The incidence of APROP among the study 
population was 1.03% and among ROP cases 
were 4.37%. There was a slight male 
preponderance with a male female ratio of 1.25:1. 
Percentage distribution of the sample according to 
birth weight shows 55.6% cases in <1 kg , 38.9% 
in 1-1.5 kg and 5.6% in >1.5 kg group.12 babies 
were <30 weeks and 8 were between 30-32 weeks 
of gestational age. Among the maternal risk 
factors 61% were primi and mode of delivery was 
by vaginal route in 66.7% cases. History of 
infertility treatment was present in 39% cases.13 
babies were born out of multiple births which 
consisted of one baby in quadruplets and one in 
triplets. Intrauterine growth retardation was 
present in 61% of cases. 
Among the postnatal risk factors some type of 
respiratory distress was shown by all the babies 
and oxygen support was needed in all the cases. 
Oxygen more than seven days was given in 10 
cases. 8 cases were given ventilator support and 
rest of the cases were on continuous positive 
airway pressure (CPAP).Hyaline membrane 
disease was present in 83.3 % cases and 66.7% 
needed surfactant therapy. 
ROP characteristics (Table 1) showed 90% of 
cases with zone 1 disease. Severe plus disease was 
present in 83.3% cases. Characteristic fundus 
lesions of APROP showed pre retinal hemorrhage 
and fibrovascular proliferation in 8 eyes and 
persistant tunica vasculosa lentis in 22 eyes. The 
mean postconceptional age of laser treatment was 
32.2 ± 1.5 weeks. 50% of APROP cases regressed 
with one sitting of laser. The mean number of 
laser spots delivered was 2829.1 ± 919.1 burns. 
Repeat laser was done in 50% of cases. ROP 
regressed well in all except 6 eyes of 4 patients at 
3 months followup. Additional intravitreal 
bevacizumab injection was given in these patients. 
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Table:1 Percentage distribution of the sample 
according to ROP characteristics 
ROP characteristics No: of 
eyes 
Percent 
APROP Present 36 100.0 
Absent 0 0.0 
Zone 
1 32 88.9 
2 4 11.1 
Plus disease 
Severe 30 83.3 
Moderate 6 16.7 
post conceptional age at laser 
treatment 
29 - 32 26 72.2 
33 - 35 10 27.8 
Mean ± SD 32.2 ± 1.5 
No:of sittings 
 
One 18 50.0 
>one 18 50.0 
No: of laser spots 
<=2400 16 44.4 
>2400 20 55.6 
Mean ± SD 2829.1 ± 919.1 
 
Association of structural outcome with post natal 
parameters shows significance for hyaline 
membrane disease (HMD) (P=0.038) and 
surfactant use (P =0.017). Favourable structural 
outcome according to ETROP 
[10]
 was present in 
32 eyes (90%) including angulation of vessels in 
two eyes and macular drag in one eye. Anatomical 
outcomes without any structural sequelae were 
achieved in 78.1% from zone I APROP and 
100% from posterior zone II APROP group (Table 
2). Unfavourable structural outcome in the form 
of partial retinal detachment (stage IV) occurred 
in 4 eyes of three patients, for which pars plana 
vitrectomy was done. Association of structural 
outcome with ROP characteristics shows 
significance for pre retinal hemorrhage and fibro 
vascular proliferation (p=0).(Table2) 
 
 
Functional outcome was normal in 77.8% cases. 
Strabismus was present in 8 eyes of 4 patients of 
which 2 babies had exotropia and 2 had esotropia.  
The predominant refractive error was myopia in 
17 eyes, of which high myopia was present in 10 
eyes. Astigmatism of more than one dioptre was 


































































































Fig:1 Percentage distribution of the sample 
according to outcome 
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Association of structural outcome with post natal 
parameters shows significance for hyaline 
membrane disease and surfactant treatment. 
(Table 3) 
 




Count Percent Count Percent 
Congenital 
pneumonia 
Present 12 85.7 2 14.3 
0.39 0.533 
Absent 17 77.3 5 22.7 
Surfactant 
Present 22 91.7 2 8.3 
5.67* 0.017 
Absent 7 58.3 5 41.7 
Oxygen duration 
4 -7 days 15 93.8 1 6.3 
3.2 0.074 
>7 days 14 70.0 6 30.0 
Blood transfusion 
Present 17 85.0 3 15.0 
0.57 0.451 
Absent 12 75.0 4 25.0 
HMD 
Present 26 86.7 4 13.3 
4.29* 0.038 
Absent 3 50.0 3 50.0 
O2 
CPAP 14 70.0 6 30.0 
3.2 0.074 
Ventilator 15 93.8 1 6.3 
                    *: - Significant at 0.05 level 
 
Discussion 
Incidence of APROP among all the ROP patients 
were 4.37% which was slightly higher when 
compared to Gunn et al which had 2.5%.
[13] 
There 
was a slight male preponderance similar to Shah 
et al 
[14]
 and  in contrast to Gunay et al.
[15] 
The 
mean birthweight was 990 grams and the mean 
gestational age was 29 weeks, which was slightly 
higher compared to other studies.
[15] 
Similar to our 
study lower gestational age and birth weight are 
associated with worse prognosis.
[16] 
The incidence 
of zone 1 changes were more when compared to a 
study by Sanghi et al 
[17]
 in which out of 29 eyes, 
10 (34.5%) had zone 1 and 19 (65.5%) had 
posterior zone 2 disease. The mean age of laser 
treatment, number of burns and time for 
regression were similar to other studies.
[17]
  
Intrauterine growth restriction and chorioam-
nionitis were associated with development of 
APROP in other studies.
[18] 
Despite early laser 
photocoagulation, the favorable outcome rates for 
APROP vary from 71% to 84%. 
[7][17]
 Preretinal 
hemorrhages and new-onset fibrovascular traction 
especially after laser is associated significantly 
with development of retinal detachment.
[19]
 
In the aggressive posterior retinopathy of 
prematurity (APROP), the group for early 
treatment of ROP (ET-ROP)
[10] 
reported 15% 
unfavorable functional outcome and 10% 
unfavorable structural outcome with laser, due to 
the development of retinal folds, retinal 
detachment, and retrolental fibroplasia. Over the 
last years, the intravitreal injection of anti-
vascular endothelial growth factor (VEGF) has 
become increasingly popular in treatment of ROP. 
Mintz-Hittner published the first prospective, 
controlled, randomized trial that proved a 
significantly lower recurrence rate of ROP 
following intravitreal bevacizumab (IVB), 
compared with laser photocoagulation, especially 
in zone I ROP.[20] Statistically significant higher 
APROP regression rate after IVB, was present as 
compared to laser photocoagulation.
[21]
  
Myopia was the predominant refractive error and 
was present in 47.2% cases of which high myopia 
constituted about 27.8 % cases similar to other 
studies.
[14] [22] 
Most preterm infants have with the 
rule astigmatism
[23] 
similar to our study. Gunay 
demonstrated significantly higher rates of 






Extremely low birth weight, low gestational age, 
zone 1 disease, preretinal hemorrhages and fibro 
vascular proliferation are significant factors 
associated with   poor structural outcome in 
aggressive posterior ROP. The incidence of 
refractive errors like high myopia   is more 
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